Budesonide-formoterol 160-4.5 10.2GM
Ended Awarded
- Contract number
- SPE2DB25FQ5A0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,225
Award facts
- Contract value 100% obligated
- $26,224.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,224.78 to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Budesonide-Formoterol 160-4.5mg inhalant medication in 10.2-gram units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for ultimate completion by September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work from its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement extending through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, serving defense and civilian healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic categories. This particular delivery order for respiratory medication supports military and veteran healthcare requirements as part of DLA's broader pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FQ5A0?
SPE2DB25FQ5A0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FQ5A0 worth?
The government has obligated $26,225 on SPE2DB25FQ5A0.
Is contract SPE2DB25FQ5A0 an order under another contract?
Yes. SPE2DB25FQ5A0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ5A0 competed?
The extent of competition for SPE2DB25FQ5A0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award